Compass Point analyst Joe Flynn raised the firm’s price target on Core Scientific (CORZ) to $20 from $18 and keeps a Buy rating on the shares. After the company announced that CoreWeave exercised its remaining option, as expected, for 120MW of additional AI/HPC infrastructure pursuant to the same terms as previously announced deals, the firm is updating its valuation to reflect the full 500MW of run-rate HPC EBITDA.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORZ:
- Core Scientific price target raised to $17 from $16 at Canaccord
- Core Scientific Expands HPC Infrastructure with CoreWeave
- Core Scientific (CORZ) Riding High on Remarkable Stock Surge
- Unusually active option classes on open October 22nd
- Core Scientific reports CoreWeave exercises option for additional infrastructure